Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs.

Bastien N, Gubbay JB, Richardson D, Sleeman K, Gubareva L, Li Y.

J Clin Microbiol. 2011 Nov;49(11):4020-1. doi: 10.1128/JCM.05069-11. Epub 2011 Sep 7. No abstract available.

2.

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

Sheu TG, Deyde VM, Garten RJ, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):354-60. doi: 10.1016/j.antiviral.2009.10.022. Epub 2009 Nov 1.

PMID:
19887086
3.

Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.

Fujisaki S, Imai M, Takashita E, Taniwaki T, Xu H, Kishida N, Yokoyama M, Sato H, Tashiro M, Odagiri T.

J Infect Chemother. 2013 Oct;19(5):891-5. doi: 10.1007/s10156-013-0589-6. Epub 2013 Mar 26.

PMID:
23529501
4.

Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.

Higgins RR, Beniprashad M, Chong-King E, Li Y, Bastien N, Low DE, Gubbay JB.

J Clin Microbiol. 2012 Jul;50(7):2500-2. doi: 10.1128/JCM.00682-12. Epub 2012 Apr 25.

5.

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.

Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, Lina B, Morfin F, Ferraris O.

J Clin Virol. 2008 Jan;41(1):25-8. Epub 2007 Dec 4.

PMID:
18055253
6.

Rapid genotypic assay for detection of oseltamivir-resistant influenza A (H1N1) viruses.

Hata M, Tanaka S, Yasui Y, Fujiwara N, Kobayashi S, Minagawa H.

J Clin Microbiol. 2010 May;48(5):1983-4. doi: 10.1128/JCM.01862-09. Epub 2010 Mar 10. No abstract available.

7.

Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR.

Hindiyeh M, Ram D, Mandelboim M, Meningher T, Hirsh S, Robinov J, Levy V, Orzitzer S, Azar R, Grossman Z, Mendelson E.

J Clin Microbiol. 2010 May;48(5):1884-7. doi: 10.1128/JCM.02540-09. Epub 2010 Mar 10.

8.

[Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].

Huang W, Li X, Tan M, Wei H, Cheng Y, Guo J, Wang Z, Xiao N, Wang D, Shu Y.

Bing Du Xue Bao. 2015 Mar;31(2):152-6. Chinese.

PMID:
26164940
9.

Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season.

Ciblak MA, Hasoksuz M, Escuret V, Valette M, Gul F, Yilmaz H, Turan N, Bozkaya E, Badur S.

J Med Virol. 2009 Sep;81(9):1645-51. doi: 10.1002/jmv.21546.

PMID:
19626608
10.

Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data.

Laplante JM, Marshall SA, Shudt M, Van TT, Reisdorf ES, Mingle LA, Shult PA, St George K.

J Clin Microbiol. 2009 May;47(5):1372-8. doi: 10.1128/JCM.01993-08. Epub 2009 Mar 25.

11.

[Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].

Reina J.

Rev Esp Quimioter. 2006 Dec;19(4):317-22. Review. Spanish. No abstract available.

12.

Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.

Pontoriero A, Baumeister E, Campos AM, Savy VL.

Rev Panam Salud Publica. 2011 Dec;30(6):634-40.

13.

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses.

Leang SK, Kwok S, Sullivan SG, Maurer-Stroh S, Kelso A, Barr IG, Hurt AC.

Influenza Other Respir Viruses. 2014 Mar;8(2):135-9.

14.

Adamantane and neuraminidase inhibitor resistance among circulating human influenza A viruses in Cuba during 2006-2010.

Piñón A, Acosta B, Valdés O, Pérez A, Muné M, Arencibia A, Savón C, Goyenechea A, Oropesa S, González G, González G, Hernández B.

Int J Antimicrob Agents. 2013 Jul;42(1):97-8. doi: 10.1016/j.ijantimicag.2013.03.008. Epub 2013 May 3. No abstract available.

PMID:
23648224
15.

Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.

Jonges M, van der Lubben IM, Dijkstra F, Verhoef L, Koopmans M, Meijer A.

Antiviral Res. 2009 Sep;83(3):290-7. doi: 10.1016/j.antiviral.2009.07.003. Epub 2009 Jul 8.

PMID:
19591877
16.

Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.

Longtin J, Patel S, Eshaghi A, Lombos E, Higgins R, Alexander D, Olsha R, Doyle J, Tran D, Sarabia A, Lee C, Bastien N, Li Y, Low D, Boivin G, Gubbay J.

J Clin Virol. 2011 Mar;50(3):257-61. doi: 10.1016/j.jcv.2010.12.007. Epub 2011 Jan 19.

PMID:
21251873
17.

Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.

Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ.

J Clin Virol. 2009 Jun;45(2):142-5. doi: 10.1016/j.jcv.2009.04.010. Epub 2009 May 17.

PMID:
19451021
18.

Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.

Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK.

Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.

PMID:
20385168
19.

The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay.

Chidlow GR, Harnett GB, Williams SH, Tempone SS, Speers DJ, Hurt AC, Deng YM, Smith DW.

J Virol Methods. 2010 Oct;169(1):47-51. doi: 10.1016/j.jviromet.2010.06.014. Epub 2010 Jun 30.

PMID:
20600329
20.

The potential impact of neuraminidase inhibitor resistant influenza.

Lackenby A, Thompson CI, Democratis J.

Curr Opin Infect Dis. 2008 Dec;21(6):626-38. doi: 10.1097/QCO.0b013e3283199797. Review.

PMID:
18978531

Supplemental Content

Support Center